BioVenture
Overview
BioVenture is a venture capital firm based in Munich, Germany, that provides seed, early, and later-stage funding to life science companies. It is associated with TVM Capital, with its managing partner also serving as the Chairman of the Board for BioVenture.
Portfolio Companies
5
Website
bioventure.deInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DiaMonTech AG | Sep 2019 | Series A | Lead |
| PROVIREX Genome Editing Therapies GmbH | Aug 2026 | VC Round | Co-investor |
| BiOligo Biotechnology (Shanghai) Co., Ltd. | Oct 2021 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioVenture based?
BioVenture is headquartered in Munich, Bavaria, Germany.
When was BioVenture founded?
Founding year information for BioVenture is not publicly available.
How many portfolio companies does BioVenture have?
BioVenture has 5 portfolio companies in Caplight's dataset.
What are some companies in BioVenture's portfolio?
Portfolio companies visible on Caplight include DiaMonTech AG, PROVIREX Genome Editing Therapies GmbH, BiOligo Biotechnology (Shanghai) Co., Ltd..
What was BioVenture's most recent investment shown here?
BioVenture's most recent investment in this portfolio sample was in PROVIREX Genome Editing Therapies GmbH in 2026.
What sectors does BioVenture focus on?
BioVenture focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does BioVenture focus on?
BioVenture typically invests at the Early stage.